Erectile Dysfunction Treatment Drugs Market By Drug Type (Phosphodiesterase Type 5 Inhibitors (Pde5 Inhibitors), Prostaglandin E1) - Growth, Future Prospects And Competitive Analysis, 2017 - 2025

Erectile dysfunction is a very common sexual problem affecting 100 million people worldwide. It is often contributed by neurological disorders, cardiovascular diseases, diabetes, hormonal imbalance and obesity. The incidence of erectile dysfunction is also proportionate to ageing, along with being associated with certain risk factors such as usage of tobacco and alcohol, certain medications and medical treatment, injuries and psychological conditions.

Globally increasing prevalence of chronic ailments, especially diabetes and cardiovascular diseases and sedentary lifestyle are anticipated to fuel the growth of erectile dysfunction treatment drugs market. Market penetration of local players manufacturing generic drugs also contributes growth to the erectile dysfunction treatment drugs market.  However, the erectile dysfunction treatment drugs market is expected to decline due to the patent expiration of the commercially available branded drugs. Social stigma about sexual issues among public in developing countries poses a challenge on the overall growth of the market. Growing trend of alternative therapies like natural medicine, surgery and other medical device might hinder the growth of erectile dysfunction treatment drugs market. Pipeline drugs under clinical trials are projected to emerge as growth opportunity of erectile dysfunction treatment drugs market in future years.

The scope of this research study entitled ‘Erectile Dysfunction Treatment Drugs Market - Growth, Future Prospects, and Competitive Analysis, 2017 – 2025’ is to provide company executives, developers, investors, and industry participants with actionable information with in-depth analysis to take tactical decisions and strategic initiatives associated to the projections in the global erectile dysfunction treatment drugs market. Major developments and trends prevailing in the global erectile dysfunction treatment drugs market and the market size and forecast are presented in the research report. Global health concern, increasing research initiatives to develop new products, rising demand among consumers and impressive pipeline product portfolio strongly boost up the growth of erectile dysfunction treatment drugs market.

This report contains the global erectile dysfunction treatment drugs market in terms of drugs type and geographical distribution. Based on the drug types, the erectile dysfunction treatment drugs market is segmented into Phosphodiesterase type 5 inhibitors (PDE5 inhibitors), Prostaglandin E1 and others. This report presents market size and forecast for every mentioned section for the period of 2015-2025 and their CAGRs for the forecast duration 2017-2025.

Geographically, the erectile dysfunction treatment drugs market is presented as five major regions which further are segmented as follow:

  • North America
    • The United States
    • Canada
  • Europe
    • The United Kingdom
    • Germany
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific
  • Latin America Middle East and Africa
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • Gulf Cooperation Council
    • Rest of Middle East and Africa

This report is comprised of data in order to determine market size with forecast of each geographical region for the years of 2015-2025 along with CAGRs for the forecast duration 2017-2025. Moreover, additional cross-sectional studies are presented in terms of type of drugs and constituent country/region level markets to gain a better insight.

This research report incorporates qualitative assessment components such as market dynamics to achieve an understanding of the current and future global market trends of erectile dysfunction treatment drugs market. Detailed description of competitive assessment tools such as partnerships and collaborations, major agreements, competitive landscape analysis, market attractiveness assessment by key players are mentioned in this report. Moreover, this research report includes profiling of major players in the erectile dysfunction treatment drugs market. The major players profiled in this report are Pfizer Inc., Dong-A Pharmaceutical Co. Ltd, Vivus, Inc., Meda Pharmaceuticals, Bayer AG, Johnson & Johnson Services, Apricus Biosciences, Eli Lilly and Company.

Erectile Dysfunction Treatment Drugs Market

Choose License Type
Published Date:  Nov 2017
Category:  Pharmaceuticals
Report ID:   58829
Report Format:   PDF
Pages:   120
Rating:    4.5 (60)
Connect With Us
+1-408-641-3282
24/7 Research Support